Shares jumped as much as 10.2% to $38.27 on an otherwise red day for U.S. markets after Guggenheim initiated coverage of Karman Holdings (KRMN) with a Buy rating and a $63 price target — implying roughly 65% upside from the prior close. For a stock that has been in freefall, the question is whether a single Wall Street endorsement can reverse months of deepening skepticism.

  • The Selloff That Set the Stage

Karman's all-time high closing price was $115.29 on January 28, 2026. Since then, shares have cratered. The stock is down more than 52% year-to-date , and shares fell 48% over the past six months. That collapse is why Guggenheim sees a window: the same business now costs a fraction of what it did eight months ago. The initiation explicitly cited more attractive valuation following year-to-date underperformance, essentially arguing the selloff overshot.

  • The Growth Numbers Behind the Bull Case Guggenheim pointed to 20–30% organic revenue growth with stable profit margins — projections that align with recent results. Record Q2 results featured 58% revenue growth, 24.4% organic growth, and a $1.3 billion backlog.

Management raised its fiscal 2026 guidance, with 95% of revenue already covered — meaning most of this year's sales are already locked in through contracts. The company expects full-year revenue between $700 million and $715 million. That backlog visibility is rare for a company this young.

  • A $63 Target Is Actually Conservative by Street Standards Guggenheim's target sits well below the Wall Street average. According to 11 analysts, the average KRMN rating is "Buy" with a 12-month price target of $87.10. Other firms are higher still: KeyBanc holds a $100 target , and Piper Sandler is at $114. Guggenheim's number is the lowest Buy-rated target on the Street, suggesting cautious optimism rather than exuberance.

  • Real Risks Lurk Below the Surface

Karman reported total debt of $875 million against just $51.7 million in cash , a leverage ratio that demands consistent cash generation. The company recently replaced its auditor after disclosing material weaknesses in internal financial controls — a red flag for governance. Valuation remains demanding, leverage is meaningful, and recent secondary offerings remind investors that shareholder supply pressure persists.

The bottom line: Guggenheim's call gives beaten-down shareholders a credible floor to point to, but a 10% pop on an initiation — not an earnings beat or contract win — underscores how starved this stock is for positive catalysts. Execution, not analyst opinions, will determine whether $63 is a waypoint or a ceiling.